Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 20152015 Jun 23.
Article in English | MEDLINE | ID: mdl-26106175

ABSTRACT

Progressive liver failure is rarely seen in tuberculosis chemoprophylaxis with isoniazid. We present a case of a 32-year-old woman admitted to our clinic reporting abdominal pain, nausea and vomiting for 2 days. The initial diagnosis was fulminant toxic hepatitis due to isoniazid chemoprophylaxis, which was treated successfully with living donor transplantation. Tuberculosis continues to be a significant public health problem. Isoniazid-related hepatotoxicity is extremely rare in adults. The only treatment in cases of fulminant liver failure is orthotopic liver transplantation from a deceased or living donor. If a deceased donor is not available or the patient refuses this treatment, living donor transplantation is the only choice. Although rare, isoniazid used as protective therapy for pulmonary tuberculosis can lead to fulminant liver failure. When cadaveric liver transplantation is not available, living donor liver transplantation is vital.


Subject(s)
Antitubercular Agents/adverse effects , Isoniazid/adverse effects , Liver Failure, Acute/chemically induced , Liver Failure, Acute/surgery , Liver Transplantation , Living Donors , Adult , Antitubercular Agents/therapeutic use , Female , Humans , Isoniazid/therapeutic use , Tuberculosis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...